Anton Belousov

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni et al. · Journal of Clinical Oncology · 2021 · 392 citations · Full text

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Daniela S. Thommen, Jens Schreiner, Philipp Müller et al. · Cancer Immunology Research · 2015 · 378 citations

Increased Dysfunction, T-regulatory Cell, Immunology +18

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 361 citations

Dc Gene Signature, Tumor Immunology, Cancer Immunosurveillance +11

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Aleix Prat, Giampaolo Bianchini, Marlène Thomas et al. · Clinical Cancer Research · 2014 · 232 citations

Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease

Donavan T. Cheng, Deog Kyeom Kim, Debra A. Cockayne et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 161 citations · Full text